Aurobindo Pharma standalone net profit declines 49.40% in the September 2018 quarter
Sales rise 3.24% to Rs 3090.38 crore
Net profit of Aurobindo Pharma declined 49.40% to Rs 380.95 crore in the quarter ended September 2018 as against Rs 752.83 crore during the previous quarter ended September 2017. Sales rose 3.24% to Rs 3090.38 crore in the quarter ended September 2018 as against Rs 2993.51 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales3090.382993.51 3 OPM %19.6434.72 -PBDT580.351056.05 -45 PBT479.41966.44 -50 NP380.95752.83 -49Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 13 2018 | 9:58 AM IST